ANDREW JIN MD
Prescription History 1083173280
Ophthalmology - Retina Specialist in Washington, DC
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ANDREW JIN MD, an active Retina Specialist specialist practicing in Washington, DC. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 133 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 40 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other DC PrescribersVs. DC Avg |
|---|---|---|---|
| Latanoprost | 40 | $20.15▼ below DC avg | ▼ Less than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 40 Medicare prescriptions for Latanoprost, about a third of the volume of the typical District Of Columbia prescriber of this medication (103). Medicare paid an average of $20.15 per fill, versus $27.09 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 65.7 30-Day Fills standardized to 30-day supplies 1,873 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 39 | $29.85▼ below DC avg | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 39 Medicare prescriptions for Prednisolone Acetate, about 66% of the volume of the typical District Of Columbia prescriber of this medication (59). Medicare paid an average of $29.85 per fill, versus $56.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 45.8 30-Day Fills standardized to 30-day supplies 1,112 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 17 | $29.58▼ below DC avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 17 Medicare prescriptions for Dorzolamide-Timolol, about a third of the volume of the typical District Of Columbia prescriber of this medication (52). Medicare paid an average of $29.58 per fill, versus $42.74 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 39 30-Day Fills standardized to 30-day supplies 1,169 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 14 | $76.24▼ below DC avg | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 14 Medicare prescriptions for Brimonidine Tartrate, about a third of the volume of the typical District Of Columbia prescriber of this medication (47). Medicare paid an average of $76.24 per fill, versus $92.40 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 24.9 30-Day Fills standardized to 30-day supplies 728 Days of Medication total across all patients in 2023 | |||
| Ketorolac Tromethamine | 12 | $18.40▼ below DC avg | ▼ Less than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2023, this provider wrote 12 Medicare prescriptions for Ketorolac Tromethamine, about a quarter of the volume of the typical District Of Columbia prescriber of this medication (58). Medicare paid an average of $18.40 per fill, versus $39.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 12.7 30-Day Fills standardized to 30-day supplies 300 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 11 | $21.86▼ below DC avg | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 11 Medicare prescriptions for Dorzolamide Hcl, about a third of the volume of the typical District Of Columbia prescriber of this medication (32). Medicare paid an average of $21.86 per fill, versus $41.89 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average DC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the DC average for this medication. 16.4 30-Day Fills standardized to 30-day supplies 492 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for ANDREW JIN MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Retina Specialist prescribing approach at this Washington, DC practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among DC prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
